Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0KRW
−3.37 BKRW
96.52 BKRW
38.86 M
About ALTEOGEN INC.
Sector
Industry
CEO
Sun-Jae Park
Website
Headquarters
Daejeon
Founded
2008
ISIN
KR7196170005
FIGI
BBG007H0XZY4
Alteogen, Inc. engages in the development, manufacture, and sale of biopharmaceuticals and anticancer drugs. Its products include technologies for anti-breast cancer drug and biosimilar, technology consulting, and other services. The company was founded on May 13, 2008 and is headquartered in Daejeon, South Korea.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 196170 is 389,500 KRW — it has increased by 9.26% in the past 24 hours. Watch ALTEOGEN INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange ALTEOGEN INC. stocks are traded under the ticker 196170.
196170 stock has risen by 4.01% compared to the previous week, the month change is a 15.41% rise, over the last year ALTEOGEN INC. has showed a 471.11% increase.
We've gathered analysts' opinions on ALTEOGEN INC. future price: according to them, 196170 price has a max estimate of 400,000.00 KRW and a min estimate of 375,000.00 KRW. Watch 196170 chart and read a more detailed ALTEOGEN INC. stock forecast: see what analysts think of ALTEOGEN INC. and suggest that you do with its stocks.
196170 reached its all-time high on Oct 22, 2024 with the price of 402,000 KRW, and its all-time low was 3,000 KRW and was reached on Dec 18, 2014. View more price dynamics on 196170 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
196170 stock is 14.74% volatile and has beta coefficient of 1.55. Track ALTEOGEN INC. stock price on the chart and check out the list of the most volatile stocks — is ALTEOGEN INC. there?
Today ALTEOGEN INC. has the market capitalization of 19.00 T, it has decreased by −0.47% over the last week.
Yes, you can track ALTEOGEN INC. financials in yearly and quarterly reports right on TradingView.
ALTEOGEN INC. is going to release the next earnings report on Nov 13, 2024. Keep track of upcoming events with our Earnings Calendar.
196170 net income for the last quarter is −2.92 B KRW, while the quarter before that showed 20.97 B KRW of net income which accounts for −113.92% change. Track more ALTEOGEN INC. financial stats to get the full picture.
No, 196170 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 4, 2024, the company has 131.00 employees. See our rating of the largest employees — is ALTEOGEN INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALTEOGEN INC. EBITDA is −5.07 B KRW, and current EBITDA margin is −6.63%. See more stats in ALTEOGEN INC. financial statements.
Like other stocks, 196170 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALTEOGEN INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALTEOGEN INC. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALTEOGEN INC. stock shows the buy signal. See more of ALTEOGEN INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.